First Hawaiian Bank Acquires 4,494 Shares of Humana Inc. (NYSE:HUM)

First Hawaiian Bank boosted its stake in shares of Humana Inc. (NYSE:HUM) by 55.1% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 12,647 shares of the insurance provider’s stock after purchasing an additional 4,494 shares during the period. First Hawaiian Bank’s holdings in Humana were worth $3,209,000 as of its most recent filing with the SEC.

Other institutional investors have also recently made changes to their positions in the company. Nordea Investment Management AB raised its position in Humana by 6.6% during the fourth quarter. Nordea Investment Management AB now owns 9,679 shares of the insurance provider’s stock worth $2,487,000 after acquiring an additional 602 shares in the last quarter. Central Pacific Bank Trust Division raised its holdings in shares of Humana by 110.7% in the 4th quarter. Central Pacific Bank Trust Division now owns 2,950 shares of the insurance provider’s stock valued at $748,000 after purchasing an additional 1,550 shares during the period. Everence Capital Management Inc. raised its holdings in shares of Humana by 57.5% in the 4th quarter. Everence Capital Management Inc. now owns 5,530 shares of the insurance provider’s stock valued at $1,403,000 after purchasing an additional 2,020 shares during the period. GAMMA Investing LLC lifted its stake in Humana by 41.0% in the 4th quarter. GAMMA Investing LLC now owns 1,906 shares of the insurance provider’s stock valued at $484,000 after purchasing an additional 554 shares during the last quarter. Finally, Versant Capital Management Inc grew its holdings in Humana by 15.5% during the fourth quarter. Versant Capital Management Inc now owns 387 shares of the insurance provider’s stock worth $98,000 after purchasing an additional 52 shares during the period. Institutional investors and hedge funds own 92.38% of the company’s stock.

Insider Buying and Selling at Humana

In other news, insider Timothy S. Huval sold 3,703 shares of Humana stock in a transaction dated Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total transaction of $948,930.78. Following the sale, the insider now directly owns 8,181 shares of the company’s stock, valued at approximately $2,096,463.06. This trade represents a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Company insiders own 0.32% of the company’s stock.

Humana Price Performance

Shares of HUM traded up $1.01 during midday trading on Wednesday, hitting $268.22. The company’s stock had a trading volume of 863,555 shares, compared to its average volume of 1,165,878. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67. Humana Inc. has a one year low of $213.31 and a one year high of $462.08. The stock has a market capitalization of $32.30 billion, a price-to-earnings ratio of 23.76, a price-to-earnings-growth ratio of 2.12 and a beta of 0.55. The company’s fifty day simple moving average is $272.82 and its two-hundred day simple moving average is $312.17.

Humana (NYSE:HUM) last released its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.48 by $0.68. The firm had revenue of $29.30 billion for the quarter, compared to analysts’ expectations of $28.66 billion. Humana had a return on equity of 13.20% and a net margin of 1.18%. As a group, equities analysts expect that Humana Inc. will post 16.14 earnings per share for the current fiscal year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.32%. The ex-dividend date of this dividend is Tuesday, December 31st. Humana’s payout ratio is 31.36%.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the company. Morgan Stanley raised their price objective on Humana from $288.00 to $301.00 and gave the company an “equal weight” rating in a research report on Tuesday, December 17th. Wells Fargo & Company reduced their price objective on shares of Humana from $387.00 to $290.00 and set an “overweight” rating for the company in a research report on Monday, November 4th. Truist Financial increased their price objective on shares of Humana from $260.00 to $290.00 and gave the company a “hold” rating in a research report on Monday. Bank of America upgraded shares of Humana from an “underperform” rating to a “neutral” rating and upped their price target for the company from $247.00 to $308.00 in a research note on Wednesday, November 6th. Finally, KeyCorp assumed coverage on shares of Humana in a research report on Friday, October 11th. They set a “sector weight” rating for the company. Twenty analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $302.00.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.